Total Payments
$11,712
2024 Payments
$1,102
Companies
38
Transactions
234
Medicare Patients
9,184
Medicare Billing
$591,048
Payment Breakdown by Category
Food & Beverage$6,076 (51.9%)
Travel$5,383 (46.0%)
Education$198.00 (1.7%)
Other$54.75 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,076 | 208 | 51.9% |
| Travel and Lodging | $5,383 | 23 | 46.0% |
| Education | $198.00 | 2 | 1.7% |
| Grant | $54.75 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $4,317 | 56 | $0 (2024) |
| Edwards Lifesciences Corporation | $2,161 | 15 | $0 (2022) |
| Medtronic, Inc. | $693.75 | 17 | $0 (2024) |
| Philips Electronics North America Corporation | $471.83 | 1 | $0 (2018) |
| PFIZER INC. | $471.09 | 23 | $0 (2024) |
| Medtronic Vascular, Inc. | $468.16 | 8 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $335.79 | 21 | $0 (2024) |
| Inari Medical, Inc. | $318.25 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $308.31 | 16 | $0 (2024) |
| ABIOMED | $239.71 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,102 | 45 | Novartis Pharmaceuticals Corporation ($242.27) |
| 2023 | $942.88 | 43 | PFIZER INC. ($156.36) |
| 2022 | $1,386 | 45 | Medtronic, Inc. ($532.89) |
| 2021 | $560.88 | 22 | Inari Medical, Inc. ($174.55) |
| 2020 | $197.75 | 13 | Abbott Laboratories ($129.00) |
| 2019 | $195.53 | 6 | Abbott Laboratories ($85.90) |
| 2018 | $4,346 | 31 | Abbott Laboratories ($3,723) |
| 2017 | $2,981 | 29 | Edwards Lifesciences Corporation ($2,062) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $14.58 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | GE HEALTHCARE | Allia (Device) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Imaging - Interventional Image Guided Systems | ||||||
| 11/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/19/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Rare Disease | ||||||
| 11/15/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/12/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $33.95 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $37.97 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Transcatheter Valve Systems | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/28/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: Transcatheter Valve Systems | ||||||
| 08/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/23/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $4.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.78 | General |
| Category: Cardiovascular | ||||||
| 07/16/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/10/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $13.61 | General |
| Category: Heart Failure and Hypertension | ||||||
| 06/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/05/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.29 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,574 | 1,847 | $247,875 | $59,761 |
| 2022 | 19 | 1,590 | 1,853 | $267,111 | $55,387 |
| 2021 | 35 | 2,491 | 2,926 | $708,635 | $179,520 |
| 2020 | 37 | 3,529 | 4,151 | $1.1M | $296,381 |
Total Patients
9,184
Total Services
10,777
Medicare Billing
$591,048
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 247 | 256 | $45,920 | $12,863 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 78 | 136 | $33,848 | $10,045 | 29.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 78 | $20,202 | $7,210 | 35.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 729 | 863 | $30,573 | $5,479 | 17.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 76 | 77 | $15,092 | $4,608 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 44 | 44 | $14,960 | $4,293 | 28.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 37 | $12,580 | $3,533 | 28.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 13 | $36,658 | $2,642 | 7.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 39 | $7,020 | $2,343 | 33.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $7,515 | $2,047 | 27.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 15 | 16 | $10,272 | $1,338 | 13.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 76 | 77 | $4,235 | $1,284 | 30.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 77 | 78 | $2,886 | $858.00 | 29.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 26 | 28 | $2,190 | $547.68 | 25.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 28 | 30 | $2,550 | $290.10 | 11.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 16 | 17 | $782.00 | $237.49 | 30.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 28 | 31 | $325.00 | $75.33 | 23.2% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 12 | 12 | $267.00 | $67.08 | 25.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 160 | 167 | $31,524 | $9,025 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 60 | 104 | $38,365 | $7,776 | 20.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 795 | 947 | $33,462 | $6,326 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 57 | 57 | $28,152 | $5,498 | 19.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 65 | $16,835 | $5,209 | 30.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 83 | 83 | $16,291 | $5,023 | 30.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 16 | 17 | $48,773 | $3,442 | 7.1% |
About Dr. Abul Khan, MD
Dr. Abul Khan, MD is a Cardiovascular Disease healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1265562110.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abul Khan, MD has received a total of $11,712 in payments from pharmaceutical and medical device companies, with $1,102 received in 2024. These payments were reported across 234 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,076).
As a Medicare-enrolled provider, Khan has provided services to 9,184 Medicare beneficiaries, totaling 10,777 services with total Medicare billing of $591,048. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Nuclear Cardiology
- Location Dallas, TX
- Active Since 03/07/2007
- Last Updated 07/26/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1265562110
Products in Payments
- Mitra Clip system (Device) $2,177
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $2,062
- AMPLATZER Occluders (Device) $1,318
- IVUS Systems (Device) $471.83
- CoreValve Evolut (Device) $467.79
- VYNDAQEL (Drug) $338.79
- LifeVest (Device) $335.79
- ELIQUIS (Drug) $248.54
- Impella (Device) $239.71
- ENTRESTO (Drug) $212.23
- FLOWTRIEVER CATHETER, S (Device) $191.94
- Assurity Pacemaker (Device) $165.21
- COREVALVE EVOLUT R (Device) $157.31
- MANTA (Device) $149.57
- VERQUVO (Drug) $148.10
- FlowTriever (Device) $126.31
- TARPEYO (Drug) $116.14
- Repatha (Biological) $112.11
- Artis Q (Device) $103.89
- Xience Alpine cornary stent system (Device) $100.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Dallas
Darren Mcguire, Md, MD
Cardiovascular Disease — Payments: $2.0M
Cardiovascular Disease $2.0M
Dr. Peter Mccullough, Md, Mph, MD, MPH
Cardiovascular Disease — Payments: $1.3M
Cardiovascular Disease $1.3M
Robert Stoler, M.d, M.D
Cardiovascular Disease — Payments: $719,078
Cardiovascular Disease $719,078
Dr. Ann Navar, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $672,005
Cardiovascular Disease $672,005
Martin Berk, M.d, M.D
Cardiovascular Disease — Payments: $493,450
Cardiovascular Disease $493,450
James De Lemos, Md, MD
Cardiovascular Disease — Payments: $448,409
Cardiovascular Disease $448,409